Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tulsi Extract for Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy
NCT05323058Phase 2Unknown
- Sponsor
- Cairo University
- Start
- Jul 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Tulsi extract in oral mucositis (OM), sponsored by Cairo University. Status: unknown.
02
Drugs
Tulsi extract
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT05323058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05323058.